Compound details
Eujambin
| Compound ID | CDAMM02954 |
|---|---|
| Common name | Eujambin | IUPAC name | [5-acetyloxy-2-[5,7-dihydroxy-4-oxo-2-(3,4,5-trihydroxyphenyl)chromen-3-yl]oxy-4-hydroxy-6-methyloxan-3-yl] 3,4,5-trihydroxybenzoate |
| Molecular formula | C30H26O17 |
| Retention time | 16.74 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 659.133 | Theoretical mz | 659.124 |
| Error | 13.54 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.325 |
| Inchi key | PYGGSPJDJQBCNV-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C(OC1C(OC=2C(=O)C=3C(O)=CC(O)=CC3OC2C=4C=C(O)C(O)=C(O)C4)OC(C)C(OC(=O)C)C1O)C5=CC(O)=C(O)C(O)=C5 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SEA |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SEA |
| P05121 | SERPINE1 | Plasminogen activator inhibitor-1 | T15556 | SEA |
| P33527 | ABCC1 | Multidrug resistance-associated protein 1 | T11288 | SEA |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SEA |
| P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha 3 | T03279 | SwissTargetPrediction |
| Q9NPH5 | NOX4 | NADPH oxidase 4 | T29741 | SEA |
| Q9GZQ4 | NMUR2 | Neuromedin-U receptor 2 | T04210 | SEA |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SEA |
| P52209 | PGD | 6-phosphogluconate dehydrogenase | T76497 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| P04637 | TP53 | Tumour suppressor p53/oncoprotein Mdm2 | T15739 | SEA |
| Q9HC98 | NEK6 | Serine/threonine-protein kinase NEK6 | T78992 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| Q13332 | PTPRS | Receptor-type tyrosine-protein phosphatase S | T10147 | SEA |
| Q99417 | MYCBP | MYCBP messenger RNA | T37298 | SEA |
| Q15717 | ELAVL1 | ELAV-like protein 1 | T78349 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T15556 | DI0037 | Asthma | [ICD-11: CA23] | P05121 | SERPINE1 |
| T15556 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | P05121 | SERPINE1 |
| T11288 | DI0167 | Gout | [ICD-11: FA25] | P33527 | ABCC1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T03279 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P51812 | RPS6KA3 |
| T29741 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q9NPH5 | NOX4 |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T76497 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P52209 | PGD |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T15739 | DI0233 | Lip/oral cavity/pharynx neoplasm | [ICD-11: 2B6E] | P04637 | TP53 |
| T15739 | DI0323 | Ovarian dysfunction | [ICD-11: 5A80] | P04637 | TP53 |
| T15739 | DI0413 | Transplant rejection | [ICD-11: NE84] | P04637 | TP53 |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T10147 | DI0057 | Bone paget disease | [ICD-11: FB85] | Q13332 | PTPRS |
| T37298 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q99417 | MYCBP |